Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 1998

View Archived Issues

RPR and Oxford BioMedica enter collaboration on gene expression control technology

Millennium delivers two drug targets for screening to Lilly

ArQule enters collaboration with R.W. Johnson for discovery of novel pharmaceuticals

Leukotriene biosynthesis inhibitors described by Ortho-McNeil for inflammatory disorders

Novel antiviral nucleoside analogues from Glaxo Wellcome, U. Michigan

Macrolactam monosaccharide of microbial origin with antifungal and antibacterial activity

Lilly patents novel mGluR modulators

Selective 5-HT1D receptor agonists from MS&D useful for migraine

Chirocaine receives first regulatory approval in Sweden

HMR patents new series of tachykinin receptor antagonists for asthma, cough and bronchitis

Pivotal clinical trials begin for Epic's sustained-release LHRH analogue

Merck broadens cancer research activities by acquiring majority holding in U.S. company

Novel orally active tumor angiogenesis inhibitors licensed by Cell Therapeutics

NIH offers new patented therapy for primary brain tumors for licensing

NIH seeks licensees for michellamine antiviral agents

Techniclone's Rx for B-cell NHL qualifies for orphan designation

Gene discovery collaboration between Bayer and Myriad extended for two more years

U.K. launch for novel antipsychotic agent: zotepine

Boehringer Ingelheim submits U.S. NDA for osteoarthritis treatment

New market release for sildenafil

Collaborative effort at SB and NPS results in development of small-molecule calcilytic

Diatide receives approvable letter for NeoTect

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...